Thank you.
Thanks to all of you for being here to discuss regenerative medicine and the future of medicine. Thank you for your world-leading research.
I think you've raised a really good point: if Canada doesn't step up to the plate, people will go overseas. They are going now. They are going for help with multiple sclerosis, for adult mesenchymal stem cells.
Could you please compare and contrast the utility of cord blood stem cells, iPS cells, adult mesenchymal stem cells, and others from the research stage through to therapeutics? Do we need all types of stem cells? Will iPSCs replace the other types?